HBW
AERI

Hazlett, Burt & Watson’s Aerie Pharmaceuticals AERI Stock Holding History

Hazlett, Burt & Watson’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,200
Closed -$338K – 654
2022
Q3 		$338K Sell
22,200
-225
-1% -$2.62K 0.33% 63
2022
Q2 		$171K Sell
22,425
-225
-1% -$1.59K 0.16% 137
2022
Q1 		$207K Buy
+22,650
New +$175K 0.16% 128

Hazlett, Burt & Watson's AERI Position: Q4 2022 in Review

Hazlett, Burt & Watson sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 22,200 shares — an estimated $338K sold.

Hazlett, Burt & Watson first reported a position in AERI in Q1 2022 and held it in 3 quarters. The position peaked at $338K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Hazlett, Burt & Watson reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 22,200 Aerie Pharmaceuticals shares in Q4 2022, an estimated $338K.
  • Hazlett, Burt & Watson first reported a position in Aerie Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Hazlett, Burt & Watson's Aerie Pharmaceuticals position peaked at $338K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Hazlett, Burt & Watson's 13F filing for Q4 2022, filed 25 Jan 2023.